Elizabeth Maxwell
Family Medicine · Lebanon, PANPI 1699123513
Payments from drug & device makers
Across 126 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$447
- Novo Nordisk$357
- Lilly USA, LLC$218
- Pfizer$197
- AstraZeneca$165
- GSK$136
- plus $650 from 14 others
What the payments were for
- Food & beverage$2,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $447 |
| Novo Nordisk | 21 | $357 |
| Lilly USA, LLC | 11 | $218 |
| Pfizer | 13 | $197 |
| AstraZeneca | 10 | $165 |
| GSK | 7 | $136 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $129 |
| Amarin Pharma, Inc. | 7 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $81 |
| Merck | 4 | $74 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Amgen | 2 | $30 |
| Organon | 1 | $26 |
| Sage Therapeutics, LLC | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
How this compares
$2,170 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 72 | $77,656 |
| TrulicityDulaglutide | 27 | $40,271 |
| JardianceEmpagliflozin | 23 | $21,886 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $6,416 |
| MyrbetriqMirabegron | 12 | $5,680 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,513 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 83 | $2,041 |
| Atorvastatin Calcium | 140 | $1,686 |
| Gabapentin | 78 | $1,574 |
| Buprenorphine | 12 | $1,568 |
| Oxycodone Hcl | 59 | $1,519 |
| Novolog FlexpenInsulin Aspart | 12 | $1,401 |
| Tramadol Hcl | 31 | $1,136 |
| Omeprazole | 87 | $1,014 |
| Chlorthalidone | 56 | $912 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $357 | $77,65672 claims |
| Lilly USA, LLCTrulicity | $218 | $40,27127 claims |
| Boehringer IngelheimJardiance | $17 | $21,88623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Lebanon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.